Regional footprint Medochemie operates 15 manufacturing facilities across Cyprus, the Netherlands, and Vietnam with export reach to 122 countries, indicating a strong supply capacity and potential for expanded contract manufacturing and regional supply agreements.

Generics leadership As one of the top 200 generic drug manufacturers globally and a founder member of Medicines for Europe, Medochemie presents opportunities for partnerships in broad portfolios of affordable medicines and co-development of generic products in multiple therapeutic areas.

Scale and capacity A workforce of up to 1,000 employees including a high proportion of scientists, and multiple manufacturing sites support high-volume production, enabling collaborations on high-demand generics and complex biosimilar or specialty generics projects.

Strategic partnerships Recent collaborations with Theramir and Consilient Health, plus a history of Pfizer engagement, signal openness to co-development, manufacturing partnerships, and accelerated market access for new generic launches.

Economic impact Medochemie contributes a sizable portion of Cyprus’ industrial exports and has a track record of export awards, suggesting strong governance, quality standards, and reliability as a partner for regulated markets and large-volume supply contracts.